20 Spam-Free Article(s) Found
Sort:
Relevance
Like
Date
Filter:
7d
All
DeepLinks
Article Searches
Molina (MOH) Reports Next Week: Wall Street Expects Earnings Growth https://www.zacks.com/stock/news/2218819/molina-moh-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2218819 Jan 31, 2024 - Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cigna (CI) Q4 Earnings Beat on Membership Growth, Dividend Up https://www.zacks.com/stock/news/2220493/cigna-ci-q4-earnings-beat-on-membership-growth-dividend-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2220493 Feb 02, 2024 - Cigna (CI) expects adjusted revenues to register a minimum growth of 20.3% from the 2023 reported figure.
Why Centene (CNC) is a Top Growth Stock for the Long-Term https://www.zacks.com/stock/news/2223365/why-centene-cnc-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2223365 Feb 08, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health (EHC) Q4 Earnings Beat on Higher Discharges https://www.zacks.com/stock/news/2223640/encompass-health-ehc-q4-earnings-beat-on-higher-discharges?cid=CS-ZC-FT-analyst_blog|earnings_article-2223640 Feb 08, 2024 - Encompass Health's (EHC) Q4 results gain on improved net patient revenue per discharge and higher net income. Management estimates 2024 adjusted EPS to be $3.77-$4.06.
3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage https://www.zacks.com/commentary/2224560/3-hmo-stocks-in-focus-despite-high-tech-costs-nursing-shortage?cid=CS-ZC-FT-industry_outlook-2224560 Feb 12, 2024 - Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.
CNC or HUM: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2226325/cnc-or-hum-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2226325 Feb 14, 2024 - CNC vs. HUM: Which Stock Is the Better Value Option?
Select Medical (SEM) Q4 Earnings Beat on Patient Admissions https://www.zacks.com/stock/news/2231204/select-medical-sem-q4-earnings-beat-on-patient-admissions?cid=CS-ZC-FT-analyst_blog|earnings_article-2231204 Feb 23, 2024 - Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million.
The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers https://www.zacks.com/stock/news/2236169/the-joint-jynt-to-report-q4-earnings-here-are-the-key-drivers?cid=CS-ZC-FT-analyst_blog|earnings_preview-2236169 Mar 05, 2024 - The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.
Why Centene (CNC) is a Top Value Stock for the Long-Term https://www.zacks.com/stock/news/2242115/why-centene-cnc-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2242115 Mar 18, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Retain Centene (CNC) Stock for Now https://www.zacks.com/stock/news/2242211/here-s-why-you-should-retain-centene-cnc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242211 Mar 18, 2024 - Robust growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Pages: 12

Page 1